The bill tasks the Secretary of Agriculture with creating an ecosystem to accelerate alternative-protein innovation: designated research centers of excellence, a new Agricultural Research Service (ARS) program on protein security, competitive facility grants to build or convert biomanufacturing capacity, workforce-development grants, and a coordinated national strategy. It also requires annual reporting to congressional agriculture committees and prohibits interpreting the law as supporting insect production for food or feed.
This is a focused industrial-policy package aimed at moving lab-scale protein technologies toward commercial scale in the United States, expanding the talent pipeline, and coordinating federal agencies to support domestic biomanufacturing. For companies, universities, and rural economies, it creates new federal funding streams, procurement and commercialization pathways, and explicit ownership and domestic-operation requirements for grant eligibility.
At a Glance
What It Does
The bill directs USDA to recognize at least three Centers of Excellence focused on food biomanufacturing and workforce development, establish a national ARS program on protein security, and create two grant programs—one for commercial-scale biomanufacturing projects and one for workforce development. It also mandates a coordinated national strategy developed with multiple federal agencies and annual congressional reporting.
Who It Affects
Higher-education institutions (including 1890 institutions), private and nonprofit biotechnology and food companies, farm and feedstock producers, USDA and ARS program managers, and state and local workforce and economic development entities. Federal science and regulatory agencies are pulled into strategy development and coordination.
Why It Matters
The bill channels dedicated federal dollars and program structures toward domestic scale-up of novel protein production and the training pipeline, which can shorten commercialization timelines, attract private capital, and alter supply-chain dependencies. It also builds a policy architecture—research, facilities, workforce, and strategy—that firms and universities will need to navigate to access grants and influence standards.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill assembles several tools to push alternative-protein technologies from research toward commercial production. It requires USDA to formally recognize at least three Centers of Excellence that will conduct research on bioprocessing and biomanufacturing and run student-success and workforce programs; one center must be led by an 1890 Institution, which targets historically Black land-grant colleges.
Those centers are intended to be hubs for open research, education, and commercialization support focused on converting under-utilized biomass into edible proteins and fats.
At the program level, the Agricultural Research Service must stand up a national program on "protein security," focused on rural prosperity and farmer income through bioprocessing and conversion of biomass into higher-value ingredients. Concurrently, USDA must create two competitive grant tracks: (1) a food biomanufacturing and production grant program that funds demonstration projects, construction of commercial-scale facilities, or retrofitting existing plants; and (2) a food bioworkforce development grant program to fund training centers, scholarships, technical assistance, and regional planning.
The production grants come with eligibility rules that prioritize U.S.-headquartered entities with at least 51 percent U.S. ownership and U.S.-held intellectual property, and each award must be at least $10 million.The bill finances these activities through multiyear authorizations and sets operational deadlines: USDA must establish the grant programs within 180 days of enactment and finalize a national protein-security strategy within a year, developed in coordination with Defense, Energy, Commerce, NIH, FDA, CDC, EPA, NSF, and OSTP. The strategy must identify barriers, propose solutions (including regulatory coordination), and set implementation plans.
Finally, USDA must report annually to relevant House and Senate agriculture committees on investments and work underway, and the bill explicitly bars construction of authority to promote insect production for food or feed.
The Five Things You Need to Know
The bill requires USDA to recognize at least three Centers of Excellence to focus on food biomanufacturing and workforce development, and mandates one center be led by an 1890 Institution.
Each food biomanufacturing grant must be at least $10 million, and eligible applicants must be U.S.-headquartered, at least 51% U.S.-owned, and deploy intellectual property owned by U.S. individuals.
USDA must establish the two competitive grant programs within 180 days of enactment and finalize the interagency national strategy on protein security within one year.
Authorizations: $15 million per year (2026–2030) for the Centers provision, $10 million per year for the ARS protein-security program, $50 million per year for the production grant program, and $25 million per year for workforce grants.
The bill requires annual reports to House and Senate agriculture committees on resources invested and the work performed, and contains a rule of construction that the Act not be read to support insect production for food or feed.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Rationale for federal intervention
The findings section bundles economic, security, and competitiveness arguments—job creation, supply-chain resilience, and global R&D competition—that frame the statute as an industrial strategy rather than a simple research program. For implementers and appropriators, these findings justify multiagency involvement and signal the bill’s dual purpose: economic development and national-security resilience.
Centers of Excellence designation and scope
USDA must recognize no fewer than three Centers of Excellence focused on bioprocessing, biomanufacturing, and converting biomass into food-grade proteins and fats. The centers may run R&D, scale-up studies, and student and workforce activities. Requiring one center led by an 1890 Institution channels capacity-building funds to historically underserved land-grant institutions, which has implications for consortium formation, grant subawards, and partner selection in center proposals.
Expands ARS grant priorities to include alternative-protein tools
The amendment inserts explicit language into competitive grant criteria to prioritize tools and production methods that increase edible-protein availability via bioprocessing and biomass conversion. Practically, this opens USDA competitive funds to projects that would previously have been categorized as nascent biotech or industrial fermentation activities, and signals reviewers to value scale-up and production-readiness work.
New ARS national program for protein security
ARS must establish a national program targeting protein security, rural prosperity, and farmer income through bioprocessing and biomass conversion. That creates a federal research lead organizing intramural research, coordinating external grants, and aligning ARS stations toward biomanufacturing-relevant problems—strain optimization, feedstock logistics, and process engineering—rather than only commodity crop improvement.
Competitive grants to build or retrofit commercial-scale capacity
USDA must create a grant program for demonstration projects, new commercial facilities, or retrofits, with a statutory minimum award of $10 million. Eligible applicants include nonprofits, for-profits, universities, National Labs, state and local governments, and consortia, but with express domestic-headquartering and ownership and IP deployment requirements—rules that will affect foreign-affiliated companies and joint ventures seeking funding.
Grants for training, scholarships, and regional coordination
This competitive grant program funds training centers, higher-education scholarships (including community colleges), technical assistance for compliance, and local planning to grow biomanufacturing clusters. Eligible applicants are broad—governmental entities, private or cooperative organizations, and federally recognized tribes—allowing states and tribal colleges to compete for capacity-building dollars.
Interagency strategy and implementation planning
USDA must lead an interagency strategy with Defense, Energy, Commerce, FDA, NIH, CDC, EPA, NSF, and OSTP. The strategy must inventory barriers across funding, regulation, and scale-up; propose solutions; and specify implementation steps. This creates a formal mechanism for aligning federal procurement, research priorities, and regulatory clarity around novel proteins, but it places heavy coordination burdens on multiple agencies.
Explicit exclusion of insect production
The bill expressly states it should not be construed to support insect production for food or feed. That narrows eligible technology pathways and signals legislative intent to prioritize plant- and fermentation-based routes, which could influence both grant decisions and the framing of the national strategy.
This bill is one of many.
Codify tracks hundreds of bills on Agriculture across all five countries.
Explore Agriculture in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- 1890 Institutions and minority-serving land-grant universities — the statute requires one Center of Excellence be led by an 1890 Institution, channeling institutional capacity-building, research funding, and workforce partnerships to historically underserved colleges.
- Domestic biotechnology and food manufacturing firms focused on bioprocessing — they gain access to construction and retrofit grants, demonstration project funding, and a clearer route to scale and commercialization through federal support and coordinated strategy.
- Rural economies and farmers growing alternative feedstocks — the ARS program and production grants target conversion of under-utilized biomass into higher-value ingredients, potentially creating new markets and higher farm-gate prices for feedstock producers.
- Community colleges and workforce-training providers — the workforce grant program funds training centers, scholarships, and technical assistance aimed at building a skilled labor pool for biomanufacturing and processing facilities.
- National laboratories and universities — centers and ARS programs expand collaborative research opportunities, infrastructure investments, and potential for public–private partnerships tied to commercialization.
Who Bears the Cost
- Federal budget and appropriations committees — the bill authorizes multi-year appropriations across several programs that will compete with other priorities and require annual funding decisions.
- USDA and ARS program management — agencies must stand up new programs, run competitions on tight timelines (180 days for grant programs), coordinate interagency strategy development, and produce annual reports, increasing administrative workload without offsetting staffing in the text.
- Small food processors and startups without required domestic ownership or U.S.-held IP — eligibility rules (U.S. headquarters, 51% U.S. ownership, U.S.-owned IP) will exclude some foreign partnerships and limit access to capital for entities with international ownership structures.
- State and local regulators and agencies — as federal funding spurs new facilities and production methods, state regulators will see increased demand for permitting, environmental review, and food-safety oversight, potentially straining capacity.
- Private investors in nonconforming technologies — by explicitly excluding insects and prioritizing certain pathways, the bill may shift venture and corporate investment toward the pathways favored by grant criteria and leave other innovations with less public support.
Key Issues
The Core Tension
The central dilemma is between accelerating domestic commercialization and preserving an open, collaborative research ecosystem. The bill intentionally channels public dollars to build sovereign capacity and protect domestic IP and jobs, but those same constraints may limit international collaboration, skew funding to established players with the administrative capacity to apply, and erect eligibility hurdles for cross-border partnerships that could otherwise speed innovation.
The bill mixes open research goals with narrowly tailored industrial-policy tools. On one hand, Centers of Excellence are positioned to support open-access research and workforce development; on the other, production grants require U.S. headquarters, majority U.S. ownership, and U.S.-held IP, which narrows the field of eligible applicants and favors domestic incumbents or companies that can restructure ownership.
That tension raises practical questions: how will USDA verify ‘‘U.S.-held IP’’ in complex licensing arrangements, and how will consortia with foreign partners structure deals to qualify?
Regulatory and scale-up uncertainty is another practical challenge. The statute calls for a national strategy and interagency coordination but does not change statutory authorities at FDA, EPA, or USDA on novel-food approvals, environmental discharges, or feedstock regulation.
That creates a risk of program-driven demand for facilities and products that face long or unclear regulatory pathways. The bill also defines the technology scope loosely ("under-utilized biomass," "biomanufacturing") while explicitly excluding insect production, which may lead to contested grant review criteria and narrower investor interest.
Finally, annual reporting and the tight deployment timelines (180 days to launch grant programs) will pressure USDA to issue rules and selection criteria quickly, increasing the likelihood of administrative appeals or litigation from disappointed applicants.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.